The pharmaceutical firm Amanta Healthcare IPO will likely be hit the market September 01, 2025 and closes on September 03, 2025. The Company has filed the RHP of this IPO. According to RHP, the corporate needs to boost ₹126.00 crore by way of IPO. The firm will subject recent shares of ₹126.00 crores by way of this IPO.
Amanta Healthcare Limited is a number one pharmaceutical firm specializing within the improvement, manufacturing, and advertising and marketing of sterile liquid parenteral merchandise. Leveraging superior Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) applied sciences, the corporate ensures high-quality packaging requirements for its various product portfolio. You can verify Amanta Healthcare IPO GMP right here.

The firm’s choices embody fluid remedy formulations comparable to IV fluids, diluents, ophthalmic options, respiratory care merchandise, irrigation options, first-aid merchandise, and eye lubricants beneath its medical units section.
Amanta operates by way of three core enterprise items:
- National Sales
- International Sales
- Product Partnering with main Indian and international pharmaceutical corporations
The firm has a robust portfolio of over 45 generic merchandise, Amanta markets its manufacturers throughout India by way of a strong community of 320 distributors and stockists. Globally, its merchandise are registered in 19 international locations and exported to 21 international locations in Fiscal 2025, together with Africa, Latin America, and the UK, whereas adhering to strict worldwide regulatory requirements. You can verify Amanta Healthcare IPO Subscription Status right here.
As of March 31, 2025, the corporate employs a talented workforce of 1,718 professionals throughout its formulation, improvement, and high quality laboratories, reinforcing its place as a trusted title in healthcare options.
Object Of the Issue :
- Funding capital expenditure necessities for civil development work and in the direction of buy of kit, plant and equipment for establishing new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
- Funding capital expenditure necessities in the direction of civil development work, buy of kit, plant and equipment for establishing new manufacturing line for SVP at Hariyala, Kheda, Gujarat
- General company functions
Company Strengths :
- Well-established producer of pharmaceutical formulations with a various product portfolio and various market.
- Large manufacturing capabilities
- Wide Domestic and International Marketing Network.
- Experienced administration staff supported by a big, various and expert workforce.
Amanta Healthcare IPO Review :
| Details | Valuation |
| PAT : Issue Price : EPS : PE Ratio : ROE : RoNW : ROCE : Debt/Equity : NAV Value : Total Assets : Market Cap : Pre Holding : Post Holding : |
₹10.50 Cr ₹126 /EQ 3.71 33.96x 12.42 % 10.89 % 13.72 % 2.02 ₹33.43 ₹381.76 Cr ₹489.25 Cr 85.60 % 63.56 % |
| Team Review : | ✔ Apply For Long Term |
👉 Amanta Healthcare IPO Review ….👈
- ■ The firm is engaged Specializes in sterile liquid parenteral merchandise with superior ABFS and ISBM applied sciences.
- ■ The firm Strong footprint in Africa, Latin America, and the UK, with compliance to worldwide rules.
- ■ The firm working in a extremely aggressive and fragmented section.
- ■ The firm high & backside line posted sturdy reported.
- ■ Based on FY25 the PE ratio of the corporate is Slightly High.
- ■ The firm Issue worth is barely aggressive based mostly on the PE ratio.
- ■ Based on FY25 the Investors can bid the Long time period view with our personal danger.
Amanta Healthcare IPO Date, Price & Details :
| IPO Open : | September 01, 2025 |
| IPO Close : | September 03, 2025 |
| Issue Type : | Book Building Issue |
| Face Value : | ₹10 Equity Share |
| Price Band : | ₹120 – ₹126 Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹126.00. Cr {1,00,00,000 Shares} |
| Fresh Issue : | ₹126.00. Cr {1,00,00,000 Shares} |
| Reserved Quota : | [QIB: 50%] [NII: 15%] [RII: 35%] |
Amanta Healthcare IPO Market Lot :
Amanta Healthcare IPO Minimum Market lot is 1 Lot with 119 shares with ₹14,994 Application quantity. The retail buyers can apply as much as 13 tons with 1,547 Shares or ₹1,94,922 quantities.
| Application | Lot | Shares | Amount Cr |
| Retail Minimum : | 1 | 119 | ₹14,994 |
| Retail Maximum : | 13 | 1,547 | ₹1,94,922 |
| S-HNI Minimum : | 14 | 1,666 | ₹2,09,916 |
| S-HNI Maximum : | 66 | 7,854 | ₹9,89,604 |
| B- HNI Minimum : | 67 | 7,983 | ₹10,04,598 |
Amanta Healthcare IPO EPS & RoNW :
| Year | EPS (₹) | RoNW % | NAV (₹) |
| 2025 | 3.71 | 10.89 | 33.43 |
| 2024 | 1.35 | 5.48 | 24.71 |
| 2023 | -0.79 | -3.36 | 23.44 |
Amanta Healthcare IPO Peer Comparison PE :
| Company | PE | EPS | RONW | NAV |
| Denis Chem Lab Ltd | 15.93 | 5.82 | 9.49 | 61.33 |
Amanta Healthcare IPO Dates :
| Open Date : | September 01, 2025 |
| Close Date : | September 03, 2025 |
| Allotment Date : | September 04, 2025 |
| Refund Date : | September 08, 2025 |
| Share Credit Date : | September 08, 2025 |
| Listing Date : | September 09, 2025 |
Amanta Healthcare IPO Form :
You can apply by way of ASBA accessible in your checking account. Log in to your financial institution’s on-line portal, go to the IPO part, and choose Amanta Healthcare IPO. You may also apply by way of an IPO type accessible on NSE and BSE web sites. Download the shape, fill it out, and submit it to your financial institution or dealer.
Amanta Healthcare Company Financial Report (Cr) :
| Year | Revenue (₹) | Expense (₹) | PAT (₹) |
| 2025 | 276.09 | 215.03 | 10.50 |
| 2024 | 281.61 | 222.85 | 3.63 |
| 2023 | 262.70 | 206.38 | -2.11 |
Company Promoters :
■ Bhavesh Patel
Quick Link :
■ DRHP Draft Prospectus
■ RHP Draft Prospectus
■ Anchor Investor
Amanta Healthcare IPO Lead Managers :
■ Beeline Capital Advisors Pvt.Ltd.
Amanta Healthcare IPO Registrar :
MUFG Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg
Vikhroli (West), Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: [email protected]
Website: www.linkintime.co.in
Note: Check Amanta Healthcare IPO allotment standing Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here
Company Address :
Amanta Healthcare Ltd.
eighth Floor, Shaligram Corporates
C.J. Marg Ambli, Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: [email protected]
Website: https://www.amanta.co.in/
Amanta Healthcare IPO FAQs :
What is Amanta Healthcare Issue?
Amanta Healthcare IPO is a Mainboard Issue. They are going to boost ₹126.00. Crores by way of IPO. The subject is priced at ₹120-₹126- per fairness share. The IPO is to be listed on NSE, and BSE.
When Amanta Healthcare Issue will open?
The IPO is to open on September 01, to September 03, 2025 for QIB, NII & RII.
What is Amanta Healthcare Issue Size?
Amanta Healthcare Issue measurement is ₹126.00 Crores.
What is the Fresh subject measurement of Amanta Healthcare Issue?
The Fresh subject measurement of Amanta Healthcare IPO ₹126.00 Cr.
What is the Amanta Healthcare Issue Minimum Size?
The minimal lot measurement 119 Shares with ₹14,994 quantity.
What is the Amanta Healthcare Issue Investors Portion?
The buyers’ portion for QIB is 50%, NII 15%, and RII 35%.
What is the Amanta Healthcare Issue Allotment Date?
Amanta Healthcare Issue allotment date is September 04, 2025
What is the Amanta Healthcare Issue Listing Date?
Amanta Healthcare Issue itemizing date is September 09, 2025. The IPO is to be listed on NSE, BSE.
Disclaimer: Stock Market Investments are Subject to Market dangers, learn all scheme Related Document Carefully Before Investing.
Source link
#Amanta #Healthcare #IPO #Dates #Review #Price #Allotment #Details #IPO #Bazar
